Libo Chen
Impact in
-
- Air Quality and Health Impacts
- Climate Change and Health Impacts
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
-
- Air Quality and Health Impacts 10
- Climate Change and Health Impacts 7
- Co-authors
- R Frantz (3 shared papers)Garvan C. Kane (3 shared papers)Nowell Mark Fine (2 shared papers)Jae K. Oh (2 shared papers)Patricia A. Pellikka (2 shared papers)Pei Gao (9 shared papers)Yonghua Hu (9 shared papers)Xiaowen Wang (9 shared papers)
- Journals
- PLoS Medicine (3 papers)Medicine (3 papers)Journal of Nuclear Medicine (3 papers)Clinical Nuclear Medicine (10 papers)BMC Genomics (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Libo Chen
78 papers receiving 2.4k citations
Libo Chen's Hit Papers
Peers
Comparison fields: 5 of 134
- Health, Toxicology and Mutagenesis 746
- Pulmonary and Respiratory Medicine 506
- Cardiology and Cardiovascular Medicine 322
- Cancer Research 200
- Environmental Engineering 182
Countries citing papers authored by Libo Chen
This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).
Fields of papers citing papers by Libo Chen
This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcome Prediction by Quantitative Right Ventricular Function Assessment in 575 Subjects Evaluated for Pulmonary Hypertension Hit paper breakdown → | 2013 | 357 |
| 2 | 2018 | 209 | |
| 3 | 2019 | 177 | |
| 4 | 2019 | 139 | |
| 5 | 2008 | 115 | |
| 6 | 2017 | 92 | |
| 7 | 2009 | 90 | |
| 8 | 2020 | 89 | |
| 9 | 2019 | 83 | |
| 10 | 2014 | 79 | |
| 11 | 2020 | 61 | |
| 12 | 2018 | 54 | |
| 13 | 2015 | 51 | |
| 14 | 2014 | 51 | |
| 15 | 2019 | 49 | |
| 16 | 2019 | 48 | |
| 17 | 2023 | 45 | |
| 18 | 2004 | 43 | |
| 19 | 2017 | 41 | |
| 20 | 2007 | 37 |
About Libo Chen
Libo Chen is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology, having authored 80 papers that have together received 2.5k indexed citations. Recurring topics across this work include Air Quality and Health Impacts (10 papers), Climate Change and Health Impacts (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (6 papers), Pulmonary Hypertension Research and Treatments (4 papers), Medical Imaging and Pathology Studies (4 papers) and Global Health Care Issues (4 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (746 citations), Pulmonary and Respiratory Medicine (506 citations), Cardiology and Cardiovascular Medicine (322 citations), Cancer Research (200 citations) and Environmental Engineering (182 citations). Libo Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include R Frantz, Garvan C. Kane, Nowell Mark Fine, Jae K. Oh, Patricia A. Pellikka, Pei Gao, Yonghua Hu, Xiaowen Wang, Yaohua Tian and Yaying Cao. Their work appears in journals such as PLoS Medicine, Medicine, Journal of Nuclear Medicine, Clinical Nuclear Medicine and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.